Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-cash Items (2016 - 2025)

International Stem Cell (ISCO) has disclosed Non-cash Items for 13 consecutive years, with $200000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 47.09% to $200000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $200000.0, a 47.09% decrease, with the full-year FY2024 number at $287000.0, down 55.85% from a year prior.
  • Non-cash Items was $200000.0 for Q3 2025 at International Stem Cell, down from $258000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $774000.0 in Q2 2022 to a low of $146000.0 in Q4 2021.
  • A 5-year average of $446000.0 and a median of $465000.0 in 2024 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: tumbled 76.71% in 2021, then soared 317.12% in 2022.
  • International Stem Cell's Non-cash Items stood at $146000.0 in 2021, then surged by 317.12% to $609000.0 in 2022, then grew by 6.73% to $650000.0 in 2023, then tumbled by 55.85% to $287000.0 in 2024, then tumbled by 30.31% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Non-cash Items are $200000.0 (Q3 2025), $258000.0 (Q2 2025), and $195000.0 (Q1 2025).